Origin Therapeutics Holdings (XCNQ:ORIG) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Origin Therapeutics Holdings's Free Cash Flow for the three months ended in Jun. 2023 was C$-0.26 Mil. Origin Therapeutics Holdings's Revenue for the three months ended in Jun. 2023 was C$0.00 Mil. Therefore, Origin Therapeutics Holdings's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Origin Therapeutics Holdings's current FCF Yield % is -52.69%.

The historical rank and industry rank for Origin Therapeutics Holdings's FCF Margin % or its related term are showing as below:

XCNQ:ORIG's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.49
* Ranked among companies with meaningful FCF Margin % only.

Origin Therapeutics Holdings FCF Margin % Historical Data

The historical data trend for Origin Therapeutics Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings FCF Margin % Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

FCF Margin %

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
FCF Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's FCF Margin % falls into.

Origin Therapeutics Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Origin Therapeutics Holdings's FCF Margin for the fiscal year that ended in Sep. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2022 )	/	Revenue (A: Sep. 2022 )
	=	-0.984	/	0
	=	%

Origin Therapeutics Holdings's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-0.26	/	0
	=	%

Origin Therapeutics Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.